Searchable abstracts of presentations at key conferences in endocrinology

ea0011p641 | Neuroendocrinology and behaviour | ECE2006

Endocrine abnormalities are common in transsexual individuals

Iqbal SJ , Baig H , Green R , Barrett J , Seal LJ

Background: The most significant hypotheses regarding biological causes of transsexualism are based on the role of environmental hormonal exposure on neural development.Aim: This study was to analyse the baseline hormonal results in a population of transsexuals attending a single clinic to identify any abnormalities in hormone levels in these individuals.Method: A retrospective cohort study was carried out using data collected from...

ea0011p643 | Neuroendocrinology and behaviour | ECE2006

Complications of hormonal therapy in male to female transsexuals is uncommon

Baig H , Iqbal SJ , Green R , Barrett J , Seal LJ

Background: Transsexuals in Britain are prescribed hormones as part of Gender Reassignment Treatment. Oestrogen therapy is associated with the development of deep vein thrombosis (DVT) with a 25 fold increased risk, and breast cancer; particularly in the older age group and smokers.Aims: To investigate the risk of developing deep vein thromboses in male to female transsexual patients who are, or have been, on oestrogen therapy, and seeing if this differs...

ea0009p183 | Clinical | BES2005

A novel calcium-sensing receptor gene mutation in a family with an extensive history of familial hypocalciuric hypercalcaemia

Ryan J , Thorne J , Hoashi S , Green A , Powell D

Familial Hypocalciuric Hypercalcaemia (FHH), originally described in 1966, was first linked to mutations in the Calcium-Sensing Receptor (CaSR) gene in 1993. FHH results from inactivating mutations affecting a single allele inherited in an autosomal dominant pattern. The calcium-sensing receptor is a cell surface-expressed G protein-coupled receptor with 1078 amino acids. Gene mutations are usually single-point in nature and result in an elevated set point for calcium sensing ...

ea0003p49 | Clinical Case Reports | BES2002

Li-Fraumeni syndrome with adrenocortical tumours producing oestrogens in the father and testosterone in his 18-month-old daughter

O'|#Connell J , Green A , O'Shea D , McKenna T

The index case, a 26-year-old man, presented with a 15-month history of gynaecomastia. Investigations revealed a large left-sided adrenal mass that secreted oestrone and oestradiol, with suppression of FSH, LH and testosterone production. It was removed in 1991 with correction of the hormonal abnormalities and follow-up has shown no recurrence to date.In April 2001 the eighteen-month old daughter of the index case developed greasy skin, acne, pubic hair...

ea0003p82 | Cytokines and Growth Factors | BES2002

IGFBP-5 regulates IGF-I mediated signaling and survival in the mouse mammary gland

Marshman E , Streuli C , Green K , White A , Westwood M

Insulin-like growth factor (IGF-I) is an important signal for mammary gland development and epithelial cell survival. Following lactation, the mammary gland undergoes involution through extensive epithelial cell apoptosis and thus, the IGF-I survival signal must be inhibited. IGF actions are regulated by association with high affinity binding proteins (IGFBPs) and the aim of this study was to investigate the expression of IGFBPs during mouse mammary gland development to determ...

ea0094p133 | Thyroid | SFEBES2023

Radioactive iodine (I-131) in hyperthyroidism: Does weight gain remain a risk?

Green Kathryn , Connelly Paul , Tough Jillian , White Anna , Kelly Chris

Background: Radioactive iodine (RAI) is a safe and effective treatment for management of hyperthyroidism caused by Graves’ disease and multinodular goitres. However, patient engagement with this therapy is limited by concerns regarding significant weight gain following treatment. We therefore aimed to audit weight changes in individuals receiving RAI within our service and identify factors that may influence this outcome.Met...

ea0099p218 | Adrenal and Cardiovascular Endocrinology | ECE2024

Severe hyponatraemia and hyperkalaemia in pre-eclampsia due to hypoadrenalism/functional hypoadrenalism

Davies Ffion , Green Timothy , Berkeley Rhiannon , Tellier Genevieve , Wilton Anthony

Pre-eclampsia is a life-threatening disease occurring in 4.6% of pregnancies characterised by multi-organ dysfunction. Placental dysfunction is implicated with release of factors causing systemic inflammation and endothelial dysfunction. Mild hyponatraemia (130–135 mmol/l) is regarded as physiological in normal pregnancy. Severe hyponatraemia (<125 mmol/l) is a rare life-threatening complication of pre-eclampsia. Severe hyponatraemia and hyperkalaemia has been reporte...

ea0099ep501 | Calcium and Bone | ECE2024

Exacerbation of hypercalcaemia in primary hyperparathyroidism following immobilisation in the elderly

Green Timothy , Berkeley Rhiannon , Tellier Genevieve , Wilton Anthony

Primary hyperparathyroidism is a common cause of hypercalcaemia increasing in prevalence with age peaking in females at 70-90 years of age (492 cases/100,000 population) and in males above 80 years of age (264 cases/100,000 population). Immobilisation hypercalcaemia is regarded as an uncommon non-parathyroid hormone dependent cause of hypercalcaemia typically occurring in young patients with spinal cord injuries and neuromuscular disorders. It is of complex physical and molecu...

ea0051p071 | Diabetes | BSPED2017

Patient centred multidisciplinary approach to diabetes education, using puppet making and film skills to facilitate learning

Dublon Victoria , Green Steve , Benitez-Castillo Malvina , Edwards Thomas , Levia Alexander

Introduction: For the last 2 years we have been giving regular diabetes education sessions in conjunction with our hospital school, based around maths skills. These went well, but we wanted to develop these further, making them more patient centred. We gained a grant from the Diabetes Research and Wellness Foundation and designed a 4 day programme with ‘The Puppet Project’ and ‘WAC arts’. This was done very much in collabaration with our hospital school who...

ea0050p277 | Neuroendocrinology and Pituitary | SFEBES2017

Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series

Boot Christopher , James R Andrew , Tsatlidis Vasileios , Gibb Fraser , Green Fiona , Neely R Dermot G

Introduction: Copeptin is the C-terminal fragment of proAVP and provides an alternative measure of AVP secretion. While direct measurement of AVP during hypertonic saline infusion has been recommended as a diagnostic test for diabetes insipidus (DI), the number of reports examining the utility of copeptin in this context is limited. Here we describe a series of cases where measurement of copeptin during saline infusion has contributed to ...